TrialThe Lancet. Haematology2019

Ruxolitinib in adult patients with secondary haemophagocytic lymphohistiocytosis: an open-label, single-centre, pilot trial.

Asra Ahmed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.